240 related articles for article (PubMed ID: 30973967)
1. A hexanucleotide repeat modifies expressivity of X-linked dystonia parkinsonism.
Westenberger A; Reyes CJ; Saranza G; Dobricic V; Hanssen H; Domingo A; Laabs BH; Schaake S; Pozojevic J; Rakovic A; Grütz K; Begemann K; Walter U; Dressler D; Bauer P; Rolfs A; Münchau A; Kaiser FJ; Ozelius LJ; Jamora RD; Rosales RL; Diesta CCE; Lohmann K; König IR; Brüggemann N; Klein C
Ann Neurol; 2019 Jun; 85(6):812-822. PubMed ID: 30973967
[TBL] [Abstract][Full Text] [Related]
2. Disease onset in X-linked dystonia-parkinsonism correlates with expansion of a hexameric repeat within an SVA retrotransposon in
Bragg DC; Mangkalaphiban K; Vaine CA; Kulkarni NJ; Shin D; Yadav R; Dhakal J; Ton ML; Cheng A; Russo CT; Ang M; Acuña P; Go C; Franceour TN; Multhaupt-Buell T; Ito N; Müller U; Hendriks WT; Breakefield XO; Sharma N; Ozelius LJ
Proc Natl Acad Sci U S A; 2017 Dec; 114(51):E11020-E11028. PubMed ID: 29229810
[TBL] [Abstract][Full Text] [Related]
3. Decreased N-TAF1 expression in X-linked dystonia-parkinsonism patient-specific neural stem cells.
Ito N; Hendriks WT; Dhakal J; Vaine CA; Liu C; Shin D; Shin K; Wakabayashi-Ito N; Dy M; Multhaupt-Buell T; Sharma N; Breakefield XO; Bragg DC
Dis Model Mech; 2016 Apr; 9(4):451-62. PubMed ID: 26769797
[TBL] [Abstract][Full Text] [Related]
4. Elucidating Hexanucleotide Repeat Number and Methylation within the X-Linked Dystonia-Parkinsonism (XDP)-Related SVA Retrotransposon in
Lüth T; Laβ J; Schaake S; Wohlers I; Pozojevic J; Jamora RDG; Rosales RL; Brüggemann N; Saranza G; Diesta CCE; Schlüter K; Tse R; Reyes CJ; Brand M; Busch H; Klein C; Westenberger A; Trinh J
Genes (Basel); 2022 Jan; 13(1):. PubMed ID: 35052466
[TBL] [Abstract][Full Text] [Related]
5. SVA insertion in X-linked Dystonia Parkinsonism alters histone H3 acetylation associated with TAF1 gene.
Petrozziello T; Dios AM; Mueller KA; Vaine CA; Hendriks WT; Glajch KE; Mills AN; Mangkalaphiban K; Penney EB; Ito N; Fernandez-Cerado C; Legarda GPA; Velasco-Andrada MS; Acuña PJ; Ang MA; Muñoz EL; Diesta CCE; Macalintal-Canlas R; Acuña G; Sharma N; Ozelius LJ; Bragg DC; Sadri-Vakili G
PLoS One; 2020; 15(12):e0243655. PubMed ID: 33315879
[TBL] [Abstract][Full Text] [Related]
6. Transcriptional Alterations in X-Linked Dystonia-Parkinsonism Caused by the SVA Retrotransposon.
Pozojevic J; Algodon SM; Cruz JN; Trinh J; Brüggemann N; Laß J; Grütz K; Schaake S; Tse R; Yumiceba V; Kruse N; Schulz K; Sreenivasan VKA; Rosales RL; Jamora RDG; Diesta CCE; Matschke J; Glatzel M; Seibler P; Händler K; Rakovic A; Kirchner H; Spielmann M; Kaiser FJ; Klein C; Westenberger A
Int J Mol Sci; 2022 Feb; 23(4):. PubMed ID: 35216353
[TBL] [Abstract][Full Text] [Related]
7. Tissue-specific and repeat length-dependent somatic instability of the X-linked dystonia parkinsonism-associated CCCTCT repeat.
Campion LN; Mejia Maza A; Yadav R; Penney EB; Murcar MG; Correia K; Gillis T; Fernandez-Cerado C; Velasco-Andrada MS; Legarda GP; Ganza-Bautista NG; Lagarde JBB; Acuña PJ; Multhaupt-Buell T; Aldykiewicz G; Supnet ML; De Guzman JK; Go C; Sharma N; Munoz EL; Ang MC; Diesta CCE; Bragg DC; Ozelius LJ; Wheeler VC
Acta Neuropathol Commun; 2022 Apr; 10(1):49. PubMed ID: 35395816
[TBL] [Abstract][Full Text] [Related]
8. Reduced neuron-specific expression of the TAF1 gene is associated with X-linked dystonia-parkinsonism.
Makino S; Kaji R; Ando S; Tomizawa M; Yasuno K; Goto S; Matsumoto S; Tabuena MD; Maranon E; Dantes M; Lee LV; Ogasawara K; Tooyama I; Akatsu H; Nishimura M; Tamiya G
Am J Hum Genet; 2007 Mar; 80(3):393-406. PubMed ID: 17273961
[TBL] [Abstract][Full Text] [Related]
9. Dissecting the Causal Mechanism of X-Linked Dystonia-Parkinsonism by Integrating Genome and Transcriptome Assembly.
Aneichyk T; Hendriks WT; Yadav R; Shin D; Gao D; Vaine CA; Collins RL; Domingo A; Currall B; Stortchevoi A; Multhaupt-Buell T; Penney EB; Cruz L; Dhakal J; Brand H; Hanscom C; Antolik C; Dy M; Ragavendran A; Underwood J; Cantsilieris S; Munson KM; Eichler EE; Acuña P; Go C; Jamora RDG; Rosales RL; Church DM; Williams SR; Garcia S; Klein C; Müller U; Wilhelmsen KC; Timmers HTM; Sapir Y; Wainger BJ; Henderson D; Ito N; Weisenfeld N; Jaffe D; Sharma N; Breakefield XO; Ozelius LJ; Bragg DC; Talkowski ME
Cell; 2018 Feb; 172(5):897-909.e21. PubMed ID: 29474918
[TBL] [Abstract][Full Text] [Related]
10. Genome editing in induced pluripotent stem cells rescues TAF1 levels in X-linked dystonia-parkinsonism.
Rakovic A; Domingo A; Grütz K; Kulikovskaja L; Capetian P; Cowley SA; Lenz I; Brüggemann N; Rosales R; Jamora D; Rolfs A; Seibler P; Westenberger A; König I; Klein C
Mov Disord; 2018 Jul; 33(7):1108-1118. PubMed ID: 30153385
[TBL] [Abstract][Full Text] [Related]
11. Mosaic divergent repeat interruptions in XDP influence repeat stability and disease onset.
Trinh J; Lüth T; Schaake S; Laabs BH; Schlüter K; Laβ J; Pozojevic J; Tse R; König I; Jamora RD; Rosales RL; Brüggemann N; Saranza G; Diesta CCE; Kaiser FJ; Depienne C; Pearson CE; Westenberger A; Klein C
Brain; 2023 Mar; 146(3):1075-1082. PubMed ID: 35481544
[TBL] [Abstract][Full Text] [Related]
12. Pathogenic SREK1 decrease in Huntington's disease lowers TAF1 mimicking X-linked dystonia parkinsonism.
Hernández IH; Cabrera JR; Santos-Galindo M; Sánchez-Martín M; Domínguez V; García-Escudero R; Pérez-Álvarez MJ; Pintado B; Lucas JJ
Brain; 2020 Jul; 143(7):2207-2219. PubMed ID: 32533168
[TBL] [Abstract][Full Text] [Related]
13. The Effect of Glucocorticoids on
Cruz SED; Bagamasbad P
J ASEAN Fed Endocr Soc; 2023; 38(1):23-30. PubMed ID: 37234925
[TBL] [Abstract][Full Text] [Related]
14. Proteomic analysis of X-linked dystonia parkinsonism disease striatal neurons reveals altered RNA metabolism and splicing.
Tshilenge KT; Bons J; Aguirre CG; Geronimo-Olvera C; Shah S; Rose J; Gerencser AA; Mak SK; Ehrlich ME; Bragg DC; Schilling B; Ellerby LM
Neurobiol Dis; 2024 Jan; 190():106367. PubMed ID: 38042508
[TBL] [Abstract][Full Text] [Related]
15. TAF1 Transcripts and Neurofilament Light Chain as Biomarkers for X-linked Dystonia-Parkinsonism.
Al Ali J; Vaine CA; Shah S; Campion L; Hakoum A; Supnet ML; Acuña P; Aldykiewicz G; Multhaupt-Buell T; Ganza NGM; Lagarde JBB; De Guzman JK; Go C; Currall B; Trombetta B; Webb PK; Talkowski M; Arnold SE; Cheah PS; Ito N; Sharma N; Bragg DC; Ozelius L; Breakefield XO
Mov Disord; 2021 Jan; 36(1):206-215. PubMed ID: 32975318
[TBL] [Abstract][Full Text] [Related]
16. X-linked dystonia-parkinsonism: over and above a repeat disorder.
Pozojevic J; Cruz JN; Westenberger A
Med Genet; 2021 Dec; 33(4):319-324. PubMed ID: 38835428
[TBL] [Abstract][Full Text] [Related]
17. X-Linked Dystonia-Parkinsonism: recent advances.
Bragg DC; Sharma N; Ozelius LJ
Curr Opin Neurol; 2019 Aug; 32(4):604-609. PubMed ID: 31116117
[TBL] [Abstract][Full Text] [Related]
18. X-linked dystonia parkinsonism syndrome (XDP, lubag): disease-specific sequence change DSC3 in TAF1/DYT3 affects genes in vesicular transport and dopamine metabolism.
Herzfeld T; Nolte D; Grznarova M; Hofmann A; Schultze JL; Müller U
Hum Mol Genet; 2013 Mar; 22(5):941-51. PubMed ID: 23184149
[TBL] [Abstract][Full Text] [Related]
19. Evidence of TAF1 dysfunction in peripheral models of X-linked dystonia-parkinsonism.
Domingo A; Amar D; Grütz K; Lee LV; Rosales R; Brüggemann N; Jamora RD; Cutiongco-Dela Paz E; Rolfs A; Dressler D; Walter U; Krainc D; Lohmann K; Shamir R; Klein C; Westenberger A
Cell Mol Life Sci; 2016 Aug; 73(16):3205-15. PubMed ID: 26879577
[TBL] [Abstract][Full Text] [Related]
20. X-linked dystonia parkinsonism: epidemiology, genetics, clinical features, diagnosis, and treatment.
Chin HL; Lin CY; Chou OH
Acta Neurol Belg; 2023 Feb; 123(1):45-55. PubMed ID: 36418540
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
